– FRANCE, Paris – Sanofi (EPA: SAN | NASDAQ: SNY) today announced the appointment of Frédéric Oudéa to its Board of Directors as a non-voting member (Censeur) effective immediately, in waiting for his formal appointment to the Board of Directors at the next AGM as Non-Executive Chairman, to replace Serge Weinberg who will step down the Board.
“I am delighted that Frédéric Oudéa has agreed to join the Board of Directors as ‘Censeur’ and, if the General Meeting agrees, to become a director and succeed me as Chairman of the Board. His experience in managing and leading the digital transformation of a large global company in a highly regulated sector, his understanding of governance matters, his financial skills, his integrity, his rigor and his sense of responsibility make me confident that he will succeed in his future role. Frédéric Oudéa and Paul Hudson (CEO) will form an excellent duo to position Sanofi as a modern healthcare company and strengthen the company as a French, European and global leader serving patients.” said Board chairman, Serge Weinberg.
About Frédéric Oudéa
Frédéric Oudéa is currently CEO of Société Générale, which he joined in 1996, and has announced that he will leave his position as CEO and Director of Société Générale in May 2023. At Société Générale, Frédéric Oudéa was successively Deputy Head and Head of the Corporate Banking arm in the United Kingdom, Head of Global Supervision and Development of the Equities Department, Group Deputy CFO in 2003, and then Group CFO in 2008, before becoming Chairman and CEO in 2009. With the separation of the functions of Chairman of the Board of Directors and CEO imposed on systemic banks in Europe for regulatory reasons, he was appointed CEO in May 2015. Before joining Société Générale, he worked for 8 years in the French senior civil service, first in the Audit Department of the Ministry of Finance, then at the Budget Ministry. Frédéric Oudéa is also a Director of Capgemini.
“I am very pleased to join the Board of Directors of Sanofi as ‘Censeur’, with the prospect of becoming Chairman, if its shareholders approve, and I would like to thank the Board of Directors and its Chairman Serge Weinberg for their trust. I am extremely motivated by the prospect of contributing to the strategy and sustainable development of Sanofi in the coming years, a leader in a strategic, high-impact healthcare sector undergoing a major transformation, and being the guarantor of the quality of the company’s governance.” commented Frédéric Oudéa.
Frédéric Oudéa is a graduate of École polytechnique and École nationale d’administration (EN.A)
About Sanofi
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally while putting sustainability and social responsibility at the center of our ambitions.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.